tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ramsay Health Care Reports Lapse of 12,889 Performance Rights

Story Highlights
  • Ramsay Health Care announced that 12,889 performance rights lapsed on 31 December 2025.
  • The cessation reflects unmet conditions on long-term incentives, slightly reducing Ramsay’s equity-linked securities.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ramsay Health Care Reports Lapse of 12,889 Performance Rights

Claim 50% Off TipRanks Premium

Ramsay Health Care ( (AU:RHC) ) has issued an announcement.

Ramsay Health Care has notified the ASX of the cessation of 12,889 performance rights (security code RHCAB) that lapsed on 31 December 2025 because the conditions attached to those rights were not met or became incapable of being satisfied. The lapse modestly reduces the company’s pool of potential equity-linked securities, indicating an adjustment to its outstanding long-term incentive instruments without affecting existing ordinary shareholders’ current holdings.

The most recent analyst rating on (AU:RHC) stock is a Hold with a A$34.80 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.

More about Ramsay Health Care

Ramsay Health Care Limited is an Australian-listed healthcare provider operating hospitals and related medical services. The company serves public and private patients and is a key player in the healthcare sector, with its shares traded on the ASX under the code RHC.

YTD Price Performance: 2.88%

Average Trading Volume: 626,697

Technical Sentiment Signal: Sell

Current Market Cap: A$8.12B

For a thorough assessment of RHC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1